|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
LEUKOCARE Has Been Granted Both ISO 9001 And ISO 13485 Certification
2/24/2010 2:14:13 PM
LEUKOCARE AG, a privately-owned company developing innovative biofunctional surfaces using its proprietary stabilizing postcoating technology, today announced that it has successfully established a Quality Management System (QMS) in accordance with ISO 9001:2008 and ISO 13485:2003 standards for medical devices.
In order to achieve ISO standards, LEUKOCARE implemented a QMS for its operations to ensure consistent and high quality of the company’s development processes. KEMA Quality B.V. audited LEUKOCARE for the design, development, manufacturing and distribution of technologies and products for biofunctional surface engineering and stabilisation of biomolecules in the field of medical devices, diagnostics, research products and biopharmaceuticals.
“By achieving ISO certification, LEUKOCARE can now offer full quality assurance in terms of development and implementation of our postcoating technology”, stated Michael Scholl, CEO of LEUKOCARE. “We are developing our technology for additional product ranges and this requires us to operate only on the highest standards of international quality.”
About LEUKOCARE
LEUKOCARE is a leading solution provider of biofunctional surfaces for medical devices and stabilized proteins resistant to standard sterilization processes. As a product-focused, clinical-stage biotechnology company, LEUKOCARE uses its proprietary stabilizing postcoating technology to couple, protect and elute biofunctional molecules. LEUKOCARE can functionalize a wide variety of surfaces including orthopedic implants, wound dressings, patches, stents, catheters, columns for ex-vivo blood treatment and others. LEUKOCARE leverages its comprehensive biofunctional coating expertise in product-focused industry partnerships. The company also offers its know-how in biofunctional coatings and product development to interested parties on a flexible basis, ranging from service-based collaborations to co-development partnerships. LEUKOCARE is a privately-owned biotechnology company founded in 2001 and headquartered in Munich, Germany.
For further information please visit our homepage www.leukocare.com or contact us:
|
|
|
|
|
|
|
|
|
|
|